Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
J.W. Cole Advisors Inc. Sells 16,943 Shares of Merck & Co., Inc. $MRK
Prudential PLC Cuts Stake in Merck & Co., Inc. $MRK
Daiwa Securities Group Inc. Sells 72,786 Shares of Merck & Co., Inc. $MRK
J.W. Cole Advisors Inc. Decreases Stock Holdings in Merck & Co., Inc. $MRK - Stock Observer
Merck & Co., Inc. $MRK Shares Acquired by Arrowpoint Investment Partners Singapore Pte. Ltd.
Vise Technologies Inc. Has $11.65 Million Position in Merck & Co., Inc. $MRK - Daily Political
A Look at Merck & Co Inc (MRK) After 4.8% Gain -- GF Value $118.24 vs Price $120.26
Merck (MRK) Settles Over 200 Gardasil Lawsuits for $50 Million
TD Asset Management Inc Grows Position in Merck & Co., Inc. $MRK
Cibc World Market Inc. Purchases 320,143 Shares of Merck & Co., Inc. $MRK
Aurobindo Pharma enters biologics contract manufacturing with ₹1,200-crore Telangana facility
Aurobindo Pharma enters biologics contract manufacturing with Rs 1,200-crore Telangana facility - The Economic Times
Vantus Wealth LLC Takes Position in Merck & Co., Inc. $MRK - Daily Political
Marble Wealth LLC Invests $1.13 Million in Merck & Co., Inc. $MRK
Merck & Co., Inc. (NYSE:MRK) Receives Average Recommendation of "Moderate Buy" from Analysts
CIBC Asset Management Inc Boosts Stock Holdings in Merck & Co., Inc. $MRK
BNP Paribas Has $7.64 Million Stake in Merck & Co., Inc. $MRK - Daily Political
Westpac Banking Corp Lowers Stock Position in Merck & Co., Inc. $MRK - Daily Political
Consensus meta-analysis of genome-wide association studies for Alzheimer's disease and related dementias
Approval expands PD-L1 testing onto an automated workflow to
Agilent Receives FDA Approval for Expanded Use of PD-L1 IHC 22C3 pharmDx on Dako Omnis in Esophageal Squamous Cell Carcinoma, Triple-Negative Breast Cancer, Cervical Cancer, and Gastric or Gastroesophageal Junction Adenocarcinoma | Morningstar
Merck & Co. (MRK) Announces Quarterly Dividend
Is Merck & Co., Inc. (MRK) Expanding KEYTRUDA's Reach With New EU Approval Momentum?
Natixis Advisors LLC Buys 217,330 Shares of Merck & Co., Inc. $MRK
Merck & Co., Inc. $MRK Shares Bought by One Capital Management LLC
BNP Paribas Sells 17,542 Shares of Merck & Co., Inc. $MRK
Merck & Co Inc Investor Event at ASCO Transcript
Singapore becomes first APAC market to approve MSD's Enflonsia for infant RSV prevention
Merck (MRK) Faces Securities Fraud Class Action Lawsuit Over Mis
Merck (MRK) Strengthens Capital Structure With Notes Offering
Merck's (MRK) Deep Drug Pipeline Could Power its Next Chapter
SEZ6-targeting antibody−drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial
5 Best Inexpensive Stocks to Invest In Right Now
Top 5 Undervalued Blue Chip Stocks Analysts Recommend for Smart Investing
5 Best Dividend Paying Stocks to Buy Right Now
Merck & Co., Inc. $MRK Position Reduced by Parr Mcknight Wealth Management Group LLC - Zolmax
Merck & Co., Inc. $MRK Shares Bought by Waterloo Capital L.P.
Merck & Co., Inc. $MRK Shares Sold by Nomura Asset Management Co. Ltd. - Stock Observer
MUFG Securities EMEA plc Sells 607,057 Shares of Merck & Co., Inc. $MRK
Merck & Co., Inc. $MRK Shares Sold by Railway Pension Investments Ltd
Railway Pension Investments Ltd Has $121.58 Million Stock Holdings in Merck & Co., Inc. $MRK - Stock Observer
Assessing Merck (MRK) Valuation After Mixed Short Term Performance And Conflicting Fair Value Signals
SBI Okasan Asset Management Co.Ltd. Acquires New Shares in Merck & Co., Inc. $MRK - Zolmax
Norges Bank Purchases New Holdings in Merck & Co., Inc. $MRK
Eurizon SLJ Capital Ltd Purchases New Holdings in Merck & Co., Inc. $MRK - Daily Political
8,000 Shares in Merck & Co., Inc. $MRK Acquired by SBI Okasan Asset Management Co.Ltd. - Daily Political
Merck Gets FDA Breakthrough Designation for Calderasib in NSCLC | Morningstar
Is Merck & Co. Stock Outperforming the S&P 500?
Houlihan Financial Resource Group Ltd. Acquires New Shares in Merck & Co., Inc. $MRK - Stock Observer
Alcohol consumption and oral human papillomavirus infection among men living with HIV: a cross-sectional study from the ULACNet 201 trial
Merck Congratulates Ontario Government on Expanding Pharmacy Scope to Help Improve Access to Care
Integrity Alliance LLC. Raises Stake in Merck & Co., Inc. $MRK
Geode Capital Management LLC Acquires 249,110 Shares of Merck & Co., Inc. $MRK - Stock Observer
Merck & Co., Inc. $MRK Stake Lowered by King Luther Capital Management Corp
Merck & Co., Inc. (NYSE:MRK) Plans Quarterly Dividend of $0.85 - Daily Political
Merck (MRK) Announces $0.85 Quarterly Dividend, Yield at 2.82%
Hantz Financial Services Inc. Cuts Stock Position in Merck & Co., Inc. $MRK - Stock Observer
Cary Street Partners Financial LLC Buys 5,577 Shares of Merck & Co., Inc. $MRK - Stock Observer
Merck's Next Growth Chapter Is Starting to Outshine Keytruda Risk
Sectoral Asset Management Inc. Boosts Stake in Merck & Co., Inc. $MRK
Merck & Co., Inc. (MRK) Completes $6 Billion Public Offering of Notes
RHL Group LLC Makes New Investment in Merck & Co., Inc. $MRK
Merck & Co., Inc. $MRK Shares Bought by Fisher Asset Management LLC
Choate Investment Advisors Buys 13,581 Shares of Merck & Co., Inc. $MRK
Genus Capital Management Inc. Takes Position in Merck & Co., Inc. $MRK
Legal & General Group Plc Has $2.08 Billion Stock Position in Merck & Co., Inc. $MRK - Daily Political
Choate Investment Advisors Has $10.37 Million Stake in Merck & Co., Inc. $MRK - Stock Observer
Pembrolizumab plus high-dose IL-2 in advanced clear cell renal cell carcinoma: six-year survival outcomes and molecular signatures from a phase 2 trial
Mondrian Investment Partners LTD Sells 38,085 Shares of Merck & Co., Inc. $MRK - Zolmax
Mondrian Investment Partners LTD Sells 38,085 Shares of Merck & Co., Inc. $MRK - Daily Political
Prospera Financial Services Inc Purchases 6,991 Shares of Merck & Co., Inc. $MRK - Daily Political
Dividend Stocks To Consider - May 23rd - Stock Observer
Merck (MRK) Phase 3 TroFuse-005 Trial for Endometrial Cancer Meets Primary Endpoints
Legato Capital Management LLC Purchases 8,759 Shares of Merck & Co., Inc. $MRK - Zolmax
Legato Capital Management LLC Buys 8,759 Shares of Merck & Co., Inc. $MRK
LSV Asset Management Cuts Stake in Merck & Co., Inc. $MRK
A Look at Merck & Co Inc (MRK) After 5.6% Gain -- GF Value $118.14 vs Price $122.41
Merck (MRK) and AbbVie (ABBV) Gain EU Panel Endorsements for New Treatments
Merck (MRK) Valuation Check After Key Oncology Trial Success And Positive EU Opinion
Merck (MRK) Advances Lung Cancer Treatment with New Drug Presentation
Merck & Co., Inc. $MRK Shares Bought by Pinnbrook Capital Management LP
Merck and Ecolab lead M&A funding charge
BioInvent Reveals Solid Data with its TNFR2 Antibody BI-1808 and KEYTRUDA(R) (pembrolizumab) in Advanced Ovarian Cancer at ASCO | Morningstar
Hepatitis A Market Research Report 2026-2036: Ecosystem, Marketed and Emerging Therapies, Epidemiological Analysis, Pipeline, Clinical Trial Landscape, Regulations Featuring GSK, Merck, and Sanofi
Oligometastatic Disease Market Analysis Report 2026-2036, Profiles of Leading Players - Dompe Farmaceutici, Bausch Health, Merck, Pfizer, and Glenmark Pharmaceuticals
Merck (MRK) - Expands Oncology Leadership with New Clinical Data at ASCO 2026
Griffin Asset Management Inc. Has $11.91 Million Stake in Merck & Co., Inc. $MRK - Zolmax
Eisai Deepens Body of Clinical Evidence for LENVIMA (Lenvatinib) Across Established Indications at ASCO 2026 | Morningstar
Lazard Freres Gestion S.A.S. Increases Stock Position in Merck & Co., Inc. $MRK - Zolmax
ProShare Advisors LLC Grows Stock Position in Merck & Co., Inc. $MRK - Zolmax
Banque Cantonale Vaudoise Acquires 5,765 Shares of Merck & Co., Inc. $MRK - Stock Observer
Lazard Freres Gestion S.A.S. Increases Stock Position in Merck & Co., Inc. $MRK - Daily Political
Merck & Co., Inc. $MRK Shares Sold by PNC Financial Services Group Inc. - Daily Political
Envestnet Portfolio Solutions Inc. Buys 12,461 Shares of Merck & Co., Inc. $MRK - Daily Political
Merck's Sacituzumab Tirumotecan Achieves Key Milestones in Cancer Treatment
Merck (MRK) Partners with Exelixis in Clinical Trial for Colorectal Cancer
Merck inks Keytruda supply pact to support Exelixis cancer trial
MerckCo News
US Monetary Policy Pivot: Non-Farm Payrolls, Inflation Fears, and Potential Rate Hikes
Netanyahu-Trump Rift Exposed: Ceasefire Talks Put Israeli Election Stakes in Jeopardy
US May Jobs Report: A Critical Indicator for the Fed's Interest Rate Path
Latest news
Show moreMarket Pulse: Dollar Rises, Gold Dips Post-US Jobs Data; Geopolitical Tensions Simmer
US May Jobs Report Signals Slowing Growth: A Deep Dive into Market Indicators
Hormuz Strait Oil Tanker Activity Shifts: Increased Secrecy and Market Fragmentation
US May Jobs Report Exceeds Expectations, Bolstering Economic Resilience and Shifting Fed Rate Outlook
